Scholarly publications and presentations by Rochester Regional Health's Oncology and Hematology department authors.
Submissions from 2026
10-13-2026 Palliative care referral timing and end-of-life outcomes in multiple myeloma, Muhammad Haseeb Khan, Rochester Regional Health, Nimra Niaz, Rabbia Irfan, et al.
10-5-2026 Fatal drug-induced liver injury in the setting of abemaciclib therapy for metastatic breast cancer, Ranjini Vengilote, Rochester Regional Health; Syed Usman Ehsanullah, Rochester Regional Health; and Mehul Patel, Rochester Regional Health
10-1-2026 An unusual case of severe acquired coagulopathy from cancer cachexia-related vitamin K deficiency, Kavya Balusu, Rochester Regional Health; Cher Ying Foo, Rochester Regional Health; and Peter A. Kouides, Rochester Regional Health
10-1-2026 Factor V Deficiency and Mechanical Valve Replacement: Challenges in Perioperative Hemostasis and Anticoagulation, Daniel Idoate Domench, Rochester Regional Health, Robin M. Reid, Rochester Regional Health, Dua Azim, Rochester Regional Health, et al.
10-1-2026 General dentists' approach to dental management of patients taking anticoagulants: a national survey-based assessment: pre- and post-procedure practice, Sharon Elad, Rebekah Boy, Michael C. Leo, et al.
10-1-2026 Influenza as a Less Commonly Recognized Cause of Hemophagocytic Lymphohistiocytosis: A Systematic Review of Case Reports and Case Series, Kavya Balusu, Rochester Regional Health, Ali Abdelhay, Fnu Payal, Rochester Regional Health, et al.
7-6-2026 Disparities in palliative care settings among patients with renal cell carcinoma in the United States: a nationwide population-based study, Cher Ying Foo, Rochester Regional Health; Ojasav Sehrawat, Rochester Regional Health; and Saad Jamshed, Rochester Regional Health
7-1-2026 Drug-induced hemolytic anemia due to ceftriaxone in a patient with recently identified alloantibodies: A diagnostic challenge, Kavya Balusu, Rochester Regional Health, Syed Usman Mohsin Ehsanullah, Rochester Regional Health, Jennifer Olejniczak, Rochester Regional Health, et al.
7-1-2026 Isolated Extreme Thrombocytosis as the Presenting Feature of Chronic Myeloid Leukemia-An Unusual Phenotype Treated With Plateletpheresis, Kavya Balusu, Rochester Regional Health; Abdullah A. Orakzai, Rochester Regional Health; and Farhan S. Imran, Rochester Regional Health
7-1-2026 Place of death patterns among patients with renal cell carcinoma in the United States: A 24-year nationwide analysis, Cher Ying Foo, Rochester Regional Health; Ojasav Sehrawat, Rochester Regional Health; and Saad Jamshed, Rochester Regional Health
7-1-2026 Thrombotic thrombocytopenic purpura associated with acalculous cholecystitis masquerading as immune thrombocytopenia, Kavya Balusu, Rochester Regional Health, Purva Shah, Rochester Regional Health, Nagesh Jadhav, Rochester Regional Health, et al.
7-1-2026 Vascular anatomic variant-related venous thromboembolism: what a hematologist needs to know, Himal Kharel, Zeni Kharel, Damon E. Houghton, et al.
7-1-2026 von Willebrand disease: an illustrated review, Mouhamed Yazan Abou-Ismail, Peter A. Kouides, Rochester Regional Health, Paula D. James, et al.
6-17-2026 The Goldilocks Guide to Breast Cancer: Not too Much, Not too Little, Just Right, Rachel David, Rochester Regional Health and Vatsala Kirtani, Rochester Regional Health
6-12-2026 In-hospital mortality and complications are increased in hematopoietic stem cell transplant recipients with myelodysplastic syndromes, Aniket-Vijay Rao, Rochester Regional Health, Aditya Sanjeevi, Rochester Regional Health, Daniel Jose Idoate Domench, Rochester Regional Health, et al.
6-1-2026 Association between chemotherapy-induced neuropathy and gabapentin exposure among adults receiving chemotherapy: A National Inpatient Sample study (2017-2021), Mahima Shenoi, Rochester Regional Health, Purva Shah, Rochester Regional Health, Candrika D. Khairani, Rochester Regional Health, et al.
6-1-2026 Association between gabapentinoid exposure and chemotherapy-associated peripheral neuropathy among adults starting new neurotoxic chemotherapy in a multi-hospital health system, Candrika D. Khairani, Rochester Regional Health, Mahima Shenoi, Rochester Regional Health, Purva Shah, Rochester Regional Health, et al.
6-1-2026 Association between palliative care consultation and end-of-life care intensity in multiple myeloma, Muhammad Haseeb Khan, Rochester Regional Health, Rabbia Irfan, Nimra Niaz, et al.
6-1-2026 Breast cancer screening is heating up: A novel thermophysics-based AI modality for screening subjects with BIRADS 4 or 5 mammograms, Nedal Darwish, Rochester Regional Health, Jessica Arconti Fleming, Rochester Regional Health, Carlos Gutierrez, et al.
5-27-2026 Medical Aid in Dying: History, New York's New Law, Your Responsibilities, and the Science, Brieze K. Bell, University of California, San Francisco; C Chris Reynolds, Rochester Regional Health; Lonny Shavelson, Academy of Aid-in-Dying Medicine; and Kayla St. Lucia, Rochester Regional Health
5-1-2026 PP01.138: Real-World Effectiveness and Safety of Lurbinectedin for Small Cell Lung Cancer (SCLC): Updates From Jazz EMERGE 402, Firas Badin, Philip Lammers, Geoffrey Liu, et al.
4-1-2026 429P Real-world (RW) effectiveness and safety of lurbinectedin for previously treated small cell lung cancer (SCLC): Jazz EMERGE 402, B Halmos, P Lammers, G Liu, et al.
4-1-2026 Antifibrinolytics, Amir A. Mahmoud and Peter A. Kouides, Rochester Regional Health
4-1-2026 Antiplatelet Agents, Amir A. Mahmoud and Peter A. Kouides, Rochester Regional Health
4-1-2026 Secondary Hemophagocytic Lymphohistiocytosis as the Initial Presentation of Metastatic Carcinoma of Likely Colorectal Origin, Kavya Balusu, Rochester Regional Health, Ali Abdelhay, Rochester Regional Health, Kim Sung Eun, Rochester Regional Health, et al.